plerixafor has been researched along with Non-alcoholic Fatty Liver Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bachelerie, F; Balabanian, K; Bignon, A; Boujedidi, H; Cassard-Doulcier, AM; Emilie, D; Gary-Gouy, H; Hemon, P; Naveau, S; Perlemuter, G; Prévot, S; Renoud, ML; Robert, O; Tharinger, H | 1 |
1 other study(ies) available for plerixafor and Non-alcoholic Fatty Liver Disease
Article | Year |
---|---|
CXCR4 dysfunction in non-alcoholic steatohepatitis in mice and patients.
Topics: Adult; Animals; Benzylamines; CD4-Positive T-Lymphocytes; Cell Movement; Chemokine CXCL12; Cyclams; Disease Models, Animal; Female; Heterocyclic Compounds; Humans; Lymphocyte Count; Male; Mice, Inbred C57BL; Mice, Obese; Middle Aged; Non-alcoholic Fatty Liver Disease; Receptors, CXCR; Receptors, CXCR4; Up-Regulation | 2015 |